[1]
Khan, A. et al. 2021. The HIGH BCR-ABL1 GENE PERCENTAGE AT TIME OF PRESENTATION: A TOOL TO PREDICT FAILURE IN ACHIEVING EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): A TERTIARY CARE CENTER EXPERIENCE. Pakistan Armed Forces Medical Journal. 71, Suppl-1 (Jan. 2021), S71–75. DOI:https://doi.org/10.51253/pafmj.v71iSuppl-1.3891.